1. Home
  2. CLRB vs INTJ Comparison

CLRB vs INTJ Comparison

Compare CLRB & INTJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • INTJ
  • Stock Information
  • Founded
  • CLRB 2002
  • INTJ 2016
  • Country
  • CLRB United States
  • INTJ Hong Kong
  • Employees
  • CLRB N/A
  • INTJ N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • INTJ
  • Sector
  • CLRB Health Care
  • INTJ
  • Exchange
  • CLRB Nasdaq
  • INTJ NYSE
  • Market Cap
  • CLRB 15.3M
  • INTJ 12.7M
  • IPO Year
  • CLRB N/A
  • INTJ 2024
  • Fundamental
  • Price
  • CLRB $0.31
  • INTJ $0.95
  • Analyst Decision
  • CLRB Buy
  • INTJ
  • Analyst Count
  • CLRB 2
  • INTJ 0
  • Target Price
  • CLRB $28.00
  • INTJ N/A
  • AVG Volume (30 Days)
  • CLRB 1.4M
  • INTJ 80.0K
  • Earning Date
  • CLRB 03-26-2025
  • INTJ 11-01-2024
  • Dividend Yield
  • CLRB N/A
  • INTJ N/A
  • EPS Growth
  • CLRB N/A
  • INTJ 30.19
  • EPS
  • CLRB N/A
  • INTJ 0.07
  • Revenue
  • CLRB N/A
  • INTJ $2,341,977.00
  • Revenue This Year
  • CLRB N/A
  • INTJ N/A
  • Revenue Next Year
  • CLRB N/A
  • INTJ N/A
  • P/E Ratio
  • CLRB N/A
  • INTJ $13.66
  • Revenue Growth
  • CLRB N/A
  • INTJ 25.78
  • 52 Week Low
  • CLRB $0.22
  • INTJ $0.72
  • 52 Week High
  • CLRB $4.45
  • INTJ $7.87
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 46.10
  • INTJ N/A
  • Support Level
  • CLRB $0.26
  • INTJ N/A
  • Resistance Level
  • CLRB $0.35
  • INTJ N/A
  • Average True Range (ATR)
  • CLRB 0.03
  • INTJ 0.00
  • MACD
  • CLRB 0.02
  • INTJ 0.00
  • Stochastic Oscillator
  • CLRB 61.40
  • INTJ 0.00

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.

About INTJ INTELLIGENT GROUP LTD

Intelligent Group Ltd is a professional services provider in Hong Kong that principally engages in the provision of Financial PR services. The company provides a substantial number of holistic and comprehensive Financial PR services to its clients through IJL, its key operating entity in Hong Kong. It advises its clients on their communications and reputation management efforts. Its Financial PR services include creating multi-stakeholder communications programs, arranging press conferences and interviews, participating in the preparation of news releases and shareholders' meetings, monitoring news publications, identifying shareholders, targeting potential investors, organizing corporate events, and implementing crisis management policies and procedures.

Share on Social Networks: